According to Rocket Pharmaceuticals
's latest financial reports the company has $0.37 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.37 B | 4.71% |
2022-12-31 | $0.35 B | -8.32% |
2021-12-31 | $0.38 B | -19.47% |
2020-12-31 | $0.48 B | 58.73% |
2019-12-31 | $0.30 B | 47.82% |
2018-12-31 | $0.20 B | 105.7% |
2017-12-31 | $0.10 B | -20.92% |
2016-12-31 | $0.12 B | 13.65% |
2015-12-31 | $0.11 B | 2975.73% |
2014-12-31 | $3.61 M | -71.72% |
2013-12-31 | $12.79 M | 832.43% |
2012-12-31 | $1.37 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -44.21% | ๐บ๐ธ USA |